InvestorsHub Logo
Followers 6
Posts 442
Boards Moderated 0
Alias Born 08/16/2018

Re: None

Wednesday, 09/18/2019 11:08:28 AM

Wednesday, September 18, 2019 11:08:28 AM

Post# of 426441
Is the PDUFA extension notice or the ADCOM notice between the FDA and Amarin FOIA-able? Or would it be considered confidential at this point and redacted to high heavens? Anyone with expertise here?

Seems to me it will be fully available at some point...if there was additional information (ie reason for delay, reason for ADCOM) in those notices I’d assume Amarin would want to disclose them so as to avoid potential repercussions later (if even applicable).

I’d be very surprised if something nefarious was taking place here...but I’m also surprised Amarin wouldn’t just post the actual communications they received from the FDA to provide investors with clarity and to avoid all the speculation.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News